NCT07718854
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +20 more
- Locations
-
- Tufts Medical Center Boston, Massachusetts, United States
Clinical trial condition
Ovarian Clear Cell Carcinoma
Explore clinical trials studying Ovarian Clear Cell Carcinoma. Study availability and eligibility vary by location and protocol.
12 public trials
5 recruiting studies
Ovarian Clear Cell Carcinoma trial results
NCT05281471
- Conditions
- Adnexal Diseases, DNA Virus Infections, Endocrine Gland Neoplasms, +26 more
- Locations
-
- The University of South Alabama, Mitchell Cancer Institute Mobile, Alabama, United States
- University of Arizona Cancer Center Tucson, Arizona, United States
- City of Hope Duarte, California, United States
- UC San Diego Health - Moores Cancer Center La Jolla, California, United States
Recruiting
Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100
NCT06065462
- Conditions
- Ovarian Clear Cell Carcinoma
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Recruiting
INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma
NCT07002346
- Conditions
- Ovarian Clear Cell Carcinoma
- Locations
-
- Tongji Hospital Wuhan, Hubei, China
Recruiting
A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary
NCT06279104
- Conditions
- Ovarian Clear Cell Carcinoma
- Locations
-
- Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
Not yet recruiting
TR115 in ARID1A-Mutated Advanced Solid Tumors
NCT07793318
- Conditions
- Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +18 more
- Locations
-
- Fudan University Shanghai Cancer Centre Shanghai, Shanghai Municipality, China
Not yet recruiting
Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell Carcinoma
NCT07239622
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
Not specified
Active, not recruiting
Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer
NCT05296512
- Conditions
- Gynecologic Cancer, Ovarian Clear Cell Carcinoma
- Locations
-
- University of Chicago Medicine Chicago, Illinois, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Mayo Clinic Comprehensive Cancer Center Rochester, Minnesota, United States
NCT04735861
- Conditions
- Ovarian Clear Cell Carcinoma
- Locations
-
- Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
NCT03297424
- Conditions
- Advanced Malignancies, Bronchial Neoplasms, Carcinoma, Bronchogenic, +36 more
- Locations
-
- Honor Health Scottsdale, Arizona, United States
- Sylvester Comprehensive Cancer Center / University of Miami Miller School of Medicine Miami, Florida, United States
- Columbia University Medical Center New York, United States
- South Texas Accelerated Research Therapeutics (START) San Antonio, Texas, United States